Literature DB >> 29156310

Context and characteristics of illicit drug use in coastal and interior Tanzania.

Jenny Tiberio1, Yovin Ivo Laurent2, Joel Ndayongeje3, Amani Msami4, Susie Welty5, Alois Ngonyani6, Syangu Mwankemwa7, Moza Makumbuli8, Willi McFarland9, Meghan D Morris10.   

Abstract

BACKGROUND: An increase in heroin seizures in East Africa may signal wider local consumption of illicit drugs. Most information about drug use in Tanzania is from the economic capital, Dar es Salaam, and well-travelled Zanzibar. More data are needed on the extent, trends, and characteristics of illicit drug use in the vast coast and interior of the country.
METHODS: The study was a rapid assessment, triangulating data from in-depth interviews of primary key informants (people who use drugs [PWUD]), secondary informants (police, community members, service providers), and ethnographic mapping of hotspots in 12 regions of Tanzania.
RESULTS: We conducted 436 in-depth interviews from September 2013 to August 2014. Regions were categorized as (1) nascent: drug use is beginning to take root; (2) established: drug use has existed for some time; or (3) pervasive: drug use is spreading into new sub-groups/areas. Multiple sources corroborated that illicit drug use has been increasing in all regions. Most PWUD worked in the cash economy as bus touts, labourers, fishermen, miners, or sex workers, or stole to survive or support their habit. PWUD congregated around bus stops along transit corridors, in abandoned buildings, and in low-income residential areas. Informants described less visible PWUD among military, police, and working-class people. Cannabis was the most common, smoked alone or with tobacco and heroin ("cocktail"). Heroin was available in all regions. Cocaine was less common, likely due to high price and variable availability. Substances such as petrol, shoe polish, and glue were used as inhalants.
CONCLUSIONS: Illicit drug use is widespread with variable features beyond cosmopolitan areas of Tanzania. Improving transportation infrastructure and economic opportunities combined with poverty and inequality appear key factors for increasing use. Findings call attention to increasing and widening drug use in Tanzania and the need to plan prevention, treatment, and harm-reduction measures nationally.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Africa; Heroin; Illicit drug use; Injecting drug use; Opioid; People who use drugs

Mesh:

Substances:

Year:  2017        PMID: 29156310     DOI: 10.1016/j.drugpo.2017.09.012

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  5 in total

1.  Trajectories of initiation for the heroin-based drug whoonga - qualitative evidence from South Africa.

Authors:  Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti
Journal:  Int J Drug Policy       Date:  2020-06-12

2.  The Opioid Epidemic in Africa And Its Impact.

Authors:  Ann E Kurth; Peter Cherutich; Rosabelle Conover; Nok Chhun; R Douglas Bruce; Barrot H Lambdin
Journal:  Curr Addict Rep       Date:  2018-10-30

3.  Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities.

Authors:  Kathryn E Lancaster; Angela Hetrick; Antoine Jaquet; Adebola Adedimeji; Lukoye Atwoli; Donn J Colby; Angel M Mayor; Angela Parcesepe; Jennifer Syvertsen
Journal:  J Virus Erad       Date:  2018-11-15

4.  HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data.

Authors:  Gitau Mburu; Mark Limmer; Paula Holland
Journal:  Harm Reduct J       Date:  2019-02-06

5.  rs1445776009 variants in the human ALB gene: Association with serum albumin and clinical outcomes in HIV-infected Kenyan injection substance users.

Authors:  Erick Barasa; Nathan Shaviya; Valentine Budambula; Tom Were
Journal:  Int J Health Sci (Qassim)       Date:  2021 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.